Literature DB >> 8524262

Regulation of p53-mediated apoptosis and cell cycle arrest by Steel factor.

J L Abrahamson1, J M Lee, A Bernstein.   

Abstract

Activation of the p53 protein can lead to apoptosis and cell cycle arrest. In contrast, activation of the signalling pathway controlled by the Kit receptor tyrosine kinase prevents apoptosis and promotes cell division of a number of different cell types in vivo. We have investigated the consequences of activating the Kit signalling pathway by its ligand Steel factor on these opposing functions of the p53 protein in Friend erythroleukemia cells. A temperature-sensitive p53 allele (Val-135) was introduced into the Friend erythroleukemia cell line (DP-16) which lacks endogenous p53 expression. At 38.5 degrees C, the Val-135 protein maintains a mutant conformation and has no effect on cell growth. At 32 degrees C, the mutant protein assumes wild-type properties and induces these cells to arrest in G1, terminally differentiate, and die by apoptosis. We demonstrate that Steel factor inhibits p53-mediated apoptosis and differentiation but has no effect on p53-mediated G1/S cell cycle arrest. These results demonstrate that Steel factor functions as a cell survival factor in part through the suppression of differentiation and apoptosis induced by p53 and suggest that cell cycle arrest and apoptosis may be separable functions of p53.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8524262      PMCID: PMC230950          DOI: 10.1128/MCB.15.12.6953

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  72 in total

1.  THE CELLULAR BASIS OF DIFFERENTIAL RADIOSENSITIVITY OF NORMAL AND GENETICALLY ANEMIC MICE.

Authors:  E S RUSSELL; S E BERNSTEIN; E C MCFARLAND; W R MODEEN
Journal:  Radiat Res       Date:  1963-12       Impact factor: 2.841

2.  Sensitive assay systems for detection of hemoglobin with 2,7-diaminofluorene: histochemistry and colorimetry for erythrodifferentiation.

Authors:  S Kaiho; K Mizuno
Journal:  Anal Biochem       Date:  1985-08-15       Impact factor: 3.365

3.  Transcriptional activation by wild-type but not transforming mutants of the p53 anti-oncogene.

Authors:  L Raycroft; H Y Wu; G Lozano
Journal:  Science       Date:  1990-08-31       Impact factor: 47.728

Review 4.  Hereditary anemias of the mouse: a review for geneticists.

Authors:  E S Russell
Journal:  Adv Genet       Date:  1979       Impact factor: 1.944

5.  Thymocyte apoptosis induced by p53-dependent and independent pathways.

Authors:  A R Clarke; C A Purdie; D J Harrison; R G Morris; C C Bird; M L Hooper; A H Wyllie
Journal:  Nature       Date:  1993-04-29       Impact factor: 49.962

6.  Requirement for phosphatidylinositol-3 kinase in the prevention of apoptosis by nerve growth factor.

Authors:  R Yao; G M Cooper
Journal:  Science       Date:  1995-03-31       Impact factor: 47.728

7.  Interactions between p53 and MDM2 in a mammalian cell cycle checkpoint pathway.

Authors:  C Y Chen; J D Oliner; Q Zhan; A J Fornace; B Vogelstein; M B Kastan
Journal:  Proc Natl Acad Sci U S A       Date:  1994-03-29       Impact factor: 11.205

Review 8.  Cell death: the significance of apoptosis.

Authors:  A H Wyllie; J F Kerr; A R Currie
Journal:  Int Rev Cytol       Date:  1980

9.  Induction of p21 (WAF-1/CIP1) during differentiation.

Authors:  R A Steinman; B Hoffman; A Iro; C Guillouf; D A Liebermann; M E el-Houseini
Journal:  Oncogene       Date:  1994-11       Impact factor: 9.867

10.  p53-dependent inhibition of cyclin-dependent kinase activities in human fibroblasts during radiation-induced G1 arrest.

Authors:  V Dulić; W K Kaufmann; S J Wilson; T D Tlsty; E Lees; J W Harper; S J Elledge; S I Reed
Journal:  Cell       Date:  1994-03-25       Impact factor: 41.582

View more
  15 in total

1.  Ubiquitination of p53 and p21 is differentially affected by ionizing and UV radiation.

Authors:  C G Maki; P M Howley
Journal:  Mol Cell Biol       Date:  1997-01       Impact factor: 4.272

2.  p53 regulates a G2 checkpoint through cyclin B1.

Authors:  S A Innocente; J L Abrahamson; J P Cogswell; J M Lee
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-02       Impact factor: 11.205

3.  Mammalian cells resistant to tumor suppressor genes.

Authors:  J A Pietenpol; C Lengauer; J Jordan; K W Kinzler; B Vogelstein
Journal:  Proc Natl Acad Sci U S A       Date:  1996-08-06       Impact factor: 11.205

4.  Identification of positive and negative regulatory regions involved in regulating expression of the human cytomegalovirus UL94 late promoter: role of IE2-86 and cellular p53 in mediating negative regulatory function.

Authors:  B A Wing; R A Johnson; E S Huang
Journal:  J Virol       Date:  1998-03       Impact factor: 5.103

5.  Differential activation of target cellular promoters by p53 mutants with impaired apoptotic function.

Authors:  R L Ludwig; S Bates; K H Vousden
Journal:  Mol Cell Biol       Date:  1996-09       Impact factor: 4.272

Review 6.  The p53 tumour suppressor gene: a mediator of a G1 growth arrest and of apoptosis.

Authors:  E Yonish-Rouach
Journal:  Experientia       Date:  1996-10-31

7.  p53 facilitates pRb cleavage in IL-3-deprived cells: novel pro-apoptotic activity of p53.

Authors:  E Gottlieb; M Oren
Journal:  EMBO J       Date:  1998-07-01       Impact factor: 11.598

8.  Enhancers and suppressors of testicular cancer susceptibility in single- and double-mutant mice.

Authors:  Man-Yee Josephine Lam; Kirsten K Youngren; Joseph H Nadeau
Journal:  Genetics       Date:  2004-02       Impact factor: 4.562

9.  Differential regulation of gene expression in mouse spermatogonial cells after blocking c-kit-SCF interaction with RNAi.

Authors:  Arun P Sikarwar; Murali K Rambabu; K V R Reddy
Journal:  J RNAi Gene Silencing       Date:  2008-05-27

10.  Overexpression of MN1 confers resistance to chemotherapy, accelerates leukemia onset, and suppresses p53 and Bim induction.

Authors:  Timothy S Pardee
Journal:  PLoS One       Date:  2012-08-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.